Form 8-K - Current report:
SEC Accession No. 0001493152-26-017960
Filing Date
2026-04-20
Accepted
2026-04-17 18:15:23
Documents
19
Period of Report
2026-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 54836
2 EX-4.1 ex4-1.htm EX-4.1 110741
3 EX-4.2 ex4-2.htm EX-4.2 117769
4 EX-4.3 ex4-3.htm EX-4.3 117775
5 EX-4.4 ex4-4.htm EX-4.4 119206
6 EX-10.1 ex10-1.htm EX-10.1 268061
7 EX-10.2 ex10-2.htm EX-10.2 184105
8 EX-99.1 ex99-1.htm EX-99.1 17140
9 EX-99.2 ex99-2.htm EX-99.2 16492
  Complete submission text file 0001493152-26-017960.txt   1380868

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE envb-20260416.xsd EX-101.SCH 3011
11 XBRL LABEL FILE envb-20260416_lab.xml EX-101.LAB 34239
12 XBRL PRESENTATION FILE envb-20260416_pre.xml EX-101.PRE 22356
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3369
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 (617) 444-8400
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 26872861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)